Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study
Top Cited Papers
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 128 (7), 1805-1811
- https://doi.org/10.1053/j.gastro.2005.03.003
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Clinical evaluation and management of acute severe colitisInflammatory Bowel Diseases, 2007
- Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safetyInflammatory Bowel Diseases, 2007
- Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative ColitisInflammatory Bowel Diseases, 2004
- Rectal Dialysate and Fecal Concentrations of Neutrophil Gelatinase-Associated Lipocalin, Interleukin-8, and Tumor Necrosis Factor-α in Ulcerative ColitisThe American Journal of Gastroenterology, 1999
- A critical review of cyclosporine therapy in inflammatory bowel diseaseInflammatory Bowel Diseases, 1995
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyThe New England Journal of Medicine, 1994
- Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease.Gut, 1993
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammationThe Lancet, 1992
- Intensive intravenous treatment of ulcerative colitisGastroenterology, 1985
- INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITISThe Lancet, 1974